Material
Peptide blend
Recovery research
GLOW70 MG
BPC-157 10 mg + GHK-Cu 50 mg + TB-500 10 mg per vial. A defined blend format for component-level research.
Product code GL070
MaterialPeptide blend
Research contextComposite peptide research.
Veyvanta / profile
Compound profile
* Vial labels may use shortened names to keep the label legible. The full material and composition are stated in this profile.
Composition
BPC-157 10 MG + GHK-Cu 50 MG + TB-500 10 MG.
Research context
Composite peptide research.
Research interest
Why it draws attention
GLOW brings together three widely discussed research themes: BPC-157 signaling, copper-peptide biology, and thymosin-related tissue remodeling.
Signals researchers are following
- 01
Tissue-repair, extracellular-matrix, and wound models
- 02
Copper-peptide, angiogenesis, and inflammatory signaling
Evidence levelComponent-level evidence
Published evidence / research profile
What the published research shows
A source-led view of the findings reported to date, the maturity of the evidence, and the limits that matter when interpreting it.
Evidence levelComponent-level evidence
Common research directions
- Tissue-repair, extracellular-matrix, and wound models
- Copper-peptide, angiogenesis, and inflammatory signaling
Reported findings
BPC-157 studies report repair-related findings mainly in rodents; GHK-Cu has cell and animal data related to connective tissue; thymosin beta 4 has limited topical human wound research. The GLOW blend itself has not been clinically validated.
How to read the evidence
Component findings cannot be added together to predict a blend effect. Published thymosin beta 4 research is also not direct evidence for commercial TB-500 identity or behavior.
Selected references
Pilot Human Safety Study of Intravenous BPC-157Altern Ther Health Med (2025)View sourceGHK Limits Metal-Induced Protein Aggregation and Cell StressMetallomics (2024)View sourceThymosin Beta 4 and Mitochondrial Transfer in Tissue GraftsFree Radic Biol Med (2025)View sourceBPC-157 and Rat Achilles Tendon HealingJ Orthop Res (2003)View sourceGHK-Cu and Connective Tissue in Experimental WoundsJ Clin Invest (1993)View sourceTopical Thymosin Beta 4 in Venous UlcersAnn N Y Acad Sci (2010)View source
This summary describes published research on the named material or its components. It does not establish safety, efficacy, equivalence, or suitability of this Veyvanta research product for human use.
Lab math
Reconstitution & measurement calculator
Convert a declared vial amount and diluent volume into nominal concentration, liquid volume, and the equivalent position on a U-100 scale.
Research product
Research productGLOW / 70 MG
Component mode calculates against one declared ingredient. Total mode calculates against the full declared blend mass.
Calculated measurement
Enter a positive diluent volume and target amount to calculate.
A calculation, not a protocol
This tool performs unit conversion only. It does not recommend an amount, frequency, route, diluent, handling method, or human use. Results assume ideal mixing and a U-100 scale of 100 units per mL; validated laboratory procedures and material-specific compatibility take priority.
Product & historical codes
Current batch record
The product code identifies this material and declared strength. Supplier lot, expiry and analytical documentation are recorded separately when available.
- Batch
- GL712
- Expiry
- 3/9/28
Veyvanta internal batch record.
Find a label code
Direct product QR
This permanent link opens this exact product and strength. It does not certify an individual vial.
veyvanta.com/p/GL070Recovery research
